Campylobacter jejuni induces transcytosis of commensal bacteria across the intestinal epithelium through M-like cells

Gut Pathogens

Volumn 2, Issue 1, 2010, Pages

  Kalischuk, Lisa D ^a   Leggett, Frances ^a   Inglis, G Douglas ^a  

^a AGRICULTURE AND AGRI FOOD CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 82055172236     PISSN: None     EISSN: 17574749     Source Type: Journal    
DOI: 10.1186/1757-4749-2-14     Document Type: Article

References (51)

1. Can loss of immune tolerance cause IBD? Maul J, Duchmann R, Inflamm Bowel Dis 2008 14 Suppl 2 115 116 10.1002/ibd.20679 18816662
2. Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis. Su L, Shen L, Clayburgh DR, Nalle SC, Sullivan EA, Meddings JB, Abraham C, Turner JR, Gastroenterology 2009 136 551 563 10.1053/j.gastro.2008.10.081 19027740
3. Role of the intestinal barrier in inflammatory bowel disease. Laukoetter MG, Nava P, Nusrat A, World J Gastroenterol 2008 14 3 401 407 10.3748/wjg.14.401 18200662 (Pubitemid 351320848)
4. Significance of systemic endotoxaemia in inflammatory bowel disease. Gardiner KR, Halliday MI, Barclay GR, Milne L, Brown D, Stephens S, Maxwell RJ, Rowlands BJ, Gut 1995 36 897 901 10.1136/gut.36.6.897 7615280
5. Cytokine association with bacterial DNA in serum of patients with inflammatory bowel disease. Gutierrez A, Frances R, Amoros A, Zapater P, Garmendia M, Ndongo M, Cano R, Jover R, Such J, Perez-Mateo M, Inflamm Bowel Dis 2009 15 508 514 10.1002/ibd.20806 19058229
6. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, Meyer zum Buschenfelde KH, Clin Exp Immunol 1995 102 448 455 10.1111/j.1365-2249.1995.tb03836.x 8536356 (Pubitemid 26013210)
7. IgG antibodies against common gut bacteria are more diagnostic for Crohn's disease than IgG against mannan or flagellin. Adams RJ, Heazlewood SP, Gilshenan KS, O'Brien M, McGuckin MA, Florin TH, Am J Gastroenterol 2008 103 386 396 10.1111/j.1572-0241.2007.01577.x 17924999 (Pubitemid 351248712)
8. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Macpherson A, Khoo UY, Forgacs I, Philpott-Howard J, Bjarnason I, Gut 1996 38 365 375 10.1136/gut.38.3.365 8675088 (Pubitemid 26074316)
9. Increased epithelial uptake of protein antigens in the ileum of Crohn's disease mediated by tumour necrosis factor alpha. Soderholm JD, Streutker C, Yang PC, Paterson C, Singh PK, McKay DM, Sherman PM, Croitoru K, Perdue MH, Gut 2004 53 1817 1824 10.1136/gut.2004.041426 15542521 (Pubitemid 39556903)
10. Transepithelial transport processes at the intestinal mucosa in inflammatory bowel disease. Schurmann G, Bruwer M, Klotz A, Schmid KW, Senninger N, Zimmer KP, Int J Colorectal Dis 1999 14 41 46 10.1007/s003840050181 10207729 (Pubitemid 29295302)
11. Correlation between cyclical epithelial barrier dysfunction and bacterial translocation in the relapses of intestinal inflammation. Porras M, Martin MT, Yang PC, Jury J, Perdue MH, Vergara P, Inflamm Bowel Dis 2006 12 843 852 10.1097/01.mib.0000231571.88806.62 16954803 (Pubitemid 44352711)
12. Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population. Halfvarson J, Jess T, Magnuson A, Montgomery SM, Orholm M, Tysk C, Binder V, Jarnerot G, Inflamm Bowel Dis 2006 12 925 933 10.1097/01.mib.0000228998.29466.ac 17012962 (Pubitemid 44498280)
13. Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool. Mylonaki M, Langmead L, Pantes A, Johnson F, Rampton DS, Eur J Gastroenterol Hepatol 2004 16 775 778 10.1097/01.meg. 0000131040.38607.09 15256979 (Pubitemid 39062569)
14. Role of infections in the manifestation or reactivation of inflammatory bowel diseases. Stallmach A, Carstens O, Inflamm Bowel Dis 2002 8 213 218 10.1097/00054725-200205000-00009 11979143 (Pubitemid 34546049)
15. Risk of irritable bowel syndrome after an episode of bacterial gastroenteritis in general practice: influence of comorbidities. Ruigomez A, Garcia Rodriguez LA, Panes J, Clin Gastroenterol Hepatol 2007 5 465 469 10.1016/j.cgh.2007.02.008 17445753 (Pubitemid 46575375)
16. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Garcia Rodriguez LA, Ruigomez A, Panes J, Gastroenterology 2006 130 1588 1594 10.1053/j.gastro.2006.02.004 16697722 (Pubitemid 43668828)
17. Increased short- and long-term risk of inflammatory bowel disease after Salmonella or Campylobacter gastroenteritis. Gradel KO, Nielsen HL, Schonheyder HC, Ejlertsen T, Kristensen B, Nielsen H, Gastroenterology 2009 137 495 501 10.1053/j.gastro.2009.04.001 19361507
18. Campylobacter jejuni induces transcellular translocation of commensal bacteria via lipid rafts. Kalischuk LD, Inglis GD, Buret AG, Gut Pathog 2009 1 2 10.1186/1757-4749-1-2 19338680
19. A role for Campylobacter jejuni-induced enteritis in inflammatory bowel disease? Kalischuk LD, Buret AG, Am J Physiol Gastrointest Liver Physiol 2009 298 1 9 10.1152/ajpgi.00193.2009 19875702
20. Intestinal villous M cells: an antigen entry site in the mucosal epithelium. Jang MH, Kweon MN, Iwatani K, Yamamoto M, Terahara K, Sasakawa C, Suzuki T, Nochi T, Yokota Y, Rennert PD, et al. Proc Natl Acad Sci USA 2004 101 6110 6115 10.1073/pnas.0400969101 15071180 (Pubitemid 38520536)
21. Plasticity of the gastrointestinal epithelium: the M cell paradigm and opportunism of pathogenic microorganisms. Kerneis S, Pringault E, Semin Immunol 1999 11 205 215 10.1006/smim.1999.0176 10381866 (Pubitemid 29358579)
22. Rapid appearance of M cells after microbial challenge is restricted at the periphery of the follicle-associated epithelium of Peyer's patch. Borghesi C, Taussig MJ, Nicoletti C, Lab Invest 1999 79 1393 1401 10576210
23. Up-regulation of microsphere transport across the follicle-associated epithelium of Peyer's patch by exposure to Streptococcus pneumoniae R36a. Meynell HM, Thomas NW, James PS, Holland J, Taussig MJ, Nicoletti C, Faseb J 1999 13 611 619 10094922 (Pubitemid 29156393)
24. Antigen transport into Peyer's patches: increased uptake by constant numbers of M cells. Gebert A, Steinmetz I, Fassbender S, Wendlandt KH, Am J Pathol 2004 164 65 72 14695320 (Pubitemid 38364591)
25. Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria. Kerneis S, Bogdanova A, Kraehenbuhl JP, Pringault E, Science 1997 277 949 952 10.1126/science.277.5328.949 9252325 (Pubitemid 27366679)
26. Bacterial-associated cholera toxin and GM1 binding are required for transcytosis of classical biotype Vibrio cholerae through an in vitro M cell model system. Blanco LP, DiRita VJ, Cell Microbiol 2006 8 982 998 10.1111/j.1462-5822.2005.00681.x 16681839 (Pubitemid 43670839)
27. Reversible differentiation of Caco-2 cells reveals galectin-9 as a surface marker molecule for human follicle-associated epithelia and M cell-like cells. Pielage JF, Cichon C, Greune L, Hirashima M, Kucharzik T, Schmidt MA, Int J Biochem Cell Biol 2007 39 1886 1901 10.1016/j.biocel.2007.05.009 17596995 (Pubitemid 47321349)
28. Macrophage migration inhibitory factor plays a role in the regulation of microfold (M) cell-mediated transport in the gut. Man AL, Lodi F, Bertelli E, Regoli M, Pin C, Mulholland F, Satoskar AR, Taussig MJ, Nicoletti C, J Immunol 2008 181 5673 5680 18832726
29. Yersinia pseudotuberculosis induces transcytosis of nanoparticles across human intestinal villus epithelium via invasin-dependent macropinocytosis. Ragnarsson EG, Schoultz I, Gullberg E, Carlsson AH, Tafazoli F, Lerm M, Magnusson KE, Soderholm JD, Artursson P, Lab Invest 2008 88 1215 1226 10.1038/labinvest.2008.86 18810251
30. Molecular physiology and pathophysiology of tight junctions V. assault of the tight junction by enteric pathogens. Sears CL, Am J Physiol Gastrointest Liver Physiol 2000 279 1129 1134 11093933
31. Intestinal alkaline phosphatase is a gut mucosal defense factor maintained by enteral nutrition. Goldberg RF, Austen WG Jr, Zhang X, Munene G, Mostafa G, Biswas S, McCormack M, Eberlin KR, Nguyen JT, Tatlidede HS, et al. Proc Natl Acad Sci USA 2008 105 3551 3556 10.1073/pnas.0712140105 18292227 (Pubitemid 351723590)
32. [Digestive complications of Campylobacter enteritis]. Lazaro A, Selles H, Calvo MA, Olivares JL, Castillo J, Gomez-Lus F, Bueno M, An Esp Pediatr 1985 22 275 279 4003954
33. Characterization of M cell formation and associated mononuclear cells during indomethacin-induced intestinal inflammation. Lugering A, Floer M, Lugering N, Cichon C, Schmidt MA, Domschke W, Kucharzik T, Clin Exp Immunol 2004 136 232 238 10.1111/j.1365-2249.2004.02438.x 15086385 (Pubitemid 38543440)
34. M-cells are damaged and increased in number in inflamed human ileal mucosa. Cuvelier CA, Quatacker J, Mielants H, De Vos M, Veys E, Roels HJ, Histopathology 1994 24 417 426 10.1111/j.1365-2559.1994.tb00550.x 8088713 (Pubitemid 24192311)
35. Role of commensal bacteria in development of gut-associated lymphoid tissues and preimmune antibody repertoire. Rhee KJ, Sethupathi P, Driks A, Lanning DK, Knight KL, J Immunol 2004 172 1118 1124 14707086 (Pubitemid 38113772)
36. Epithelia under metabolic stress perceive commensal bacteria as a threat. Nazli A, Yang PC, Jury J, Howe K, Watson JL, Soderholm JD, Sherman PM, Perdue MH, McKay DM, Am J Pathol 2004 164 947 957 14982848 (Pubitemid 38235476)
37. Decreased epithelial barrier function evoked by exposure to metabolic stress and nonpathogenic E. coli is enhanced by TNF-alpha. Lewis K, Caldwell J, Phan V, Prescott D, Nazli A, Wang A, Soderholm JD, Perdue MH, Sherman PM, McKay DM, Am J Physiol Gastrointest Liver Physiol 2008 294 669 678 10.1152/ajpgi.00382.2007 18187519 (Pubitemid 351468760)
38. Cellular events and intracellular survival of Campylobacter jejuni during infection of HEp-2 cells. De Melo MA, Gabbiani G, Pechere JC, Infect Immun 1989 57 2214 2222 2731988 (Pubitemid 19186905)
39. Morphologic observations of experimental Campylobacter jejuni infection in the hamster intestinal tract. Humphrey CD, Montag DM, Pittman FE, Am J Pathol 1986 122 152 159 3942198 (Pubitemid 16108556)
40. Strain-dependent induction of epithelial cell oncosis by Campylobacter jejuni is correlated with invasion ability and is independent of cytolethal distending toxin. Kalischuk LD, Inglis GD, Buret AG, Microbiology 2007 153 2952 2963 10.1099/mic.0.2006/003962-0 17768238 (Pubitemid 47517056)
41. Electron microscopic appearance of the chronic Campylobacter jejuni enteritis of mice. Gao JX, Ma BL, Xie YL, Huang DS, Chin Med J (Engl) 1991 104 1005 1010 1782809
42. The invasion of epithelial cell lines and the intestinal epithelium of infant mice by Campylobacter jejuni/coli. Newell DG, Pearson A, J Diarrhoeal Dis Res 1984 2 19 26 6501816
43. Micro-managing the executioner: pathogen targeting of mitochondria. Blanke SR, Trends Microbiol 2005 13 64 71 10.1016/j.tim.2004.12.007 15680765 (Pubitemid 40174865)
44. Caco-2 cells express a combination of colonocyte and enterocyte phenotypes. Engle MJ, Goetz GS, Alpers DH, J Cell Physiol 1998 174 362 369 10.1002/(SICI)1097-4652(199803)174:3<362::AID-JCP10>3.0.CO;2-B 9462698 (Pubitemid 28068713)
45. Mid-life crisis for M cells. Owen RL, Gut 1998 42 11 12 10.1136/gut.42.1.11 9505877 (Pubitemid 28228379)
46. Pathogenesis of aphthoid ulcers in Crohn's disease: correlative findings by magnifying colonoscopy, electron microscopy, and immunohistochemistry. Fujimura Y, Kamoi R, Iida M, Gut 1996 38 724 732 10.1136/gut.38.5.724 8707119 (Pubitemid 26167481)
47. Increased uptake of non-pathogenic E. coli via the follicle-associated epithelium in longstanding ileal Crohn's disease. Keita AV, Salim SY, Jiang T, Yang PC, Franzen L, Soderkvist P, Magnusson KE, Soderholm JD, J Pathol 2008 215 135 144 10.1002/path.2337 18348161 (Pubitemid 351786032)
48. Peyer's patches and M cells as potential sites of the inflammatory onset in Crohn's disease. Gullberg E, Soderholm JD, Ann N Y Acad Sci 2006 1072 218 232 10.1196/annals.1326.028 17057202 (Pubitemid 44448455)
49. A point-source outbreak of campylobacteriosis associated with consumption of raw milk. Korlath JA, Osterholm MT, Judy LA, Forfang JC, Robinson RA, J Infect Dis 1985 152 592 596 4031557 (Pubitemid 15018692)
50. In vivo tracking of Campylobacter jejuni by using a novel recombinant expressing green fluorescent protein. Mixter PF, Klena JD, Flom GA, Siegesmund AM, Konkel ME, Appl Environ Microbiol 2003 69 2864 2874 10.1128/AEM.69.5.2864- 2874.2003 12732559 (Pubitemid 36560367)
51. Method for assay of intestinal disaccharidases. Dahlqvist A, Anal Biochem 1964 7 18 25 10.1016/0003-2697(64)90115-0 14106916